Difference between revisions of "Medical Technology Group"

From Powerbase
Jump to: navigation, search
Line 1: Line 1:
−
The Medical Technology Group (MTG) is a trade organization, working for different companies, patient groups, charities and other trade associations in the pharmaceutical industry. The MTG was launched in 2000 to make medical technologies available to everyone who needs them. The MTG works towards achieving a cutting edge NHS where patients are guaranteed access to effective medical technologies <ref> ABHI website [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx  Medical Technology Group], accessed Feb 2011</ref> The MTG does not have any competitors, like they write on their homepage, they are “the only UK coalition of industry groups and patient charities working together to improve patient access to effective medical technologies” <ref> MTG website [http://www.mtg.org.uk/ Competitors], accessed Feb 2011</ref>.
+
The Medical Technology Group (MTG) is a trade organization, working for different companies, patient groups, charities and other trade associations in the pharmaceutical industry. The MTG was launched in 2000 to make medical technologies available to everyone who needs them. The MTG works towards achieving a cutting edge NHS where patients are guaranteed access to effective medical technologies. <ref> ABHI website [http://www.abhi.org.uk/key-issues/public-affairs/medical-technology-group.aspx  Medical Technology Group], accessed Feb 2011</ref> The MTG does not have any competitors, like they write on their homepage, they are “the only UK coalition of industry groups and patient charities working together to improve patient access to effective medical technologies”. <ref> MTG website [http://www.mtg.org.uk/ Competitors], accessed Feb 2011</ref>
  
  
−
AdvaMed, a members of the MTG, writes on their homepage that, “the Medical Technology Group represents drug and device manufacturers and trade associations on all aspects of federal and state regulation of medical technology, including the requirements of the Food and Drug Administration, Health Care Financing Administration, Centers for Disease Control and Prevention, the Federal Trade Commission, and State Medicaid Agencies” <ref> AdvaMed website [http://www.advamed.org/MemberPortal/Membership/associate/associate_member_roster.htm Associate Members], accessed Mars 2011</ref>.
+
AdvaMed, a members of the MTG, writes on their homepage that, “the Medical Technology Group represents drug and device manufacturers and trade associations on all aspects of federal and state regulation of medical technology, including the requirements of the Food and Drug Administration, Health Care Financing Administration, Centers for Disease Control and Prevention, the Federal Trade Commission, and State Medicaid Agencies”. <ref> AdvaMed website [http://www.advamed.org/MemberPortal/Membership/associate/associate_member_roster.htm Associate Members], accessed Mars 2011</ref>
  
 
==Economy==
 
==Economy==
−
Many, including The MTG, believe that that the uptake of medical technologies is not as good as it should be in the UK. The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55 000 individuals. Barbara Harpham, Medical Technology Group chairman and director of Heart Research UK claims that, UK lag behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use <ref> Nursing Times [http://www.nursingtimes.net/whats-new-in-nursing/news-topics/health-informatics/nhs-must-boost-use-of-technology-or-risk-falling-behind/5008942.article NHS 'must boost use of technology' or risk falling behind], accessed April 2011</ref>. Norman Lamb MP, the Liberal Democrat Shadow Health Secretary, agree that it should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients” (http://www.scottishhealthcare.com/2009/11/page/2/).
+
Many, including The MTG, believe that that the uptake of medical technologies is not as good as it should be in the UK. The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55 000 individuals. Barbara Harpham, Medical Technology Group chairman and director of Heart Research UK claims that, UK lag behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use. <ref> Nursing Times website [http://www.nursingtimes.net/whats-new-in-nursing/news-topics/health-informatics/nhs-must-boost-use-of-technology-or-risk-falling-behind/5008942.article NHS 'must boost use of technology' or risk falling behind], accessed April 2011</ref> Norman Lamb MP, the Liberal Democrat Shadow Health Secretary, agree that it should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. <ref> Scottish Healthcare website [http://www.scottishhealthcare.com/2009/11/page/2/ Medical Technology Group Warns Against ‘Slow-Tech’ NHS], accessed April 2011</ref>
  
−
“The global medical technology market is estimated to be worth £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. The USA is the largest market worth over £70bn and has a strong supply base with the majority of world’s largest medical technology companies originating in the country.” (http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf). “The UK spends just 4.5% of its healthcare budget on technology, compared with a European average of 6.3%. This leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate” (http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=11).
+
 
 +
“The global medical technology market is estimated to be worth £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. The USA is the largest market worth over £70bn and has a strong supply base with the majority of world’s largest medical technology companies originating in the country”. <ref> HM Government [http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf Strength and
 +
Opportunity], accessed Mars 2011</ref>. “The UK spends just 4.5% of its healthcare budget on technology, compared with a European average of 6.3%. This leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate”. <ref> MTG website [http://www.mtg.org.uk/go.cfm?do=Page.Show&pid=11 MTG Policy Statements], accessed Feb 2011</ref>
  
 
==MTG members==
 
==MTG members==

Revision as of 13:39, 21 April 2011

The Medical Technology Group (MTG) is a trade organization, working for different companies, patient groups, charities and other trade associations in the pharmaceutical industry. The MTG was launched in 2000 to make medical technologies available to everyone who needs them. The MTG works towards achieving a cutting edge NHS where patients are guaranteed access to effective medical technologies. [1] The MTG does not have any competitors, like they write on their homepage, they are “the only UK coalition of industry groups and patient charities working together to improve patient access to effective medical technologies”. [2]


AdvaMed, a members of the MTG, writes on their homepage that, “the Medical Technology Group represents drug and device manufacturers and trade associations on all aspects of federal and state regulation of medical technology, including the requirements of the Food and Drug Administration, Health Care Financing Administration, Centers for Disease Control and Prevention, the Federal Trade Commission, and State Medicaid Agencies”. [3]

Economy

Many, including The MTG, believe that that the uptake of medical technologies is not as good as it should be in the UK. The UK medical technology sector in 2010 consists of 3034 companies generating a turnover of £13.1bn and employing 55 000 individuals. Barbara Harpham, Medical Technology Group chairman and director of Heart Research UK claims that, UK lag behind many other European countries, with problems like hospitals denying patients NICE-approved technologies because they lack the facilities or staff to support their use. [4] Norman Lamb MP, the Liberal Democrat Shadow Health Secretary, agree that it should be more focus on medical technology. He says that, “adoption of medical technologies is often both cost effective and in the patient’s interest. Up until now, the NHS has been slow to recognise the value of technology. This has to change if we are to maximise the effective use of resources for the benefit of patients”. [5]


“The global medical technology market is estimated to be worth £150-170bn and the proportion of healthcare expenditure spent on medical technology is increasing. The USA is the largest market worth over £70bn and has a strong supply base with the majority of world’s largest medical technology companies originating in the country”. [6]. “The UK spends just 4.5% of its healthcare budget on technology, compared with a European average of 6.3%. This leads to British patients missing out, for example life saving pacemakers are implanted in Germany at twice the UK rate”. [7]

MTG members

AdvaMed, Abbot Medical Optics, AntiCoagulation Europe, ARMA, Arrhythmia Alliance, Arthritis Care, Atrial Fibrillation Association, Association of British Healthcare Industries, BD, Bladder and Bowel Foundation, Boston Scientific, British Cardiac Patients’ Association, Cardiomyopathy Association, Circulation Foundation, ConvaTec, CR Bard, Dexcom, Eucomed, FABLE, FEmISA, Heart Research UK, ICD Group, Inappropriate Sinus Tachycardia Info and Support, International Alliance of Patients’ Organizations, INPUT, Johnson & Johnson, The Juvenile Diabetes Research Foundation, The Lindsay Leg Club Foundation, Medtronic, National Rheumatoid Arthritis Society, The Patients Association, Patient Information Forum, Pelvic Pain Support Network, Roche Diagnostics, SADS UK, St Jude Medical, STARS, Stryker, Transplant Support Network, Zimmer[8]

It also includes the following trade associations (in 2010): Association of British Healthcare Industries, AdvaMed, Eucomed as well as individual medical technology companies.[9]

What the MTG wants

The MTG believes that:
1. Medical Technology gives value for money to the NHS, patients and taxpayers.
2. Uptake of medical technology in the UK is not as good as it should be.
3. People need more information about medical technologies to help unlock their value.[10]

It therefore wants:

  • More information for patients on what technologies are available and appropriate for them, to enable shared decision‐making.
  • Training/guidance for clinicians on the choices of medical technology available and how to use them.
  • Dissemination of guidance and best practice (location of centres of excellence) that explains the patient and cost benefits of appropriate use of medical technology to those commissioning services (i.e medical technology interventions included within NICE quality standards).
  • Involvement of patients in commissioning decisions/oversight.
  • Top‐down systems that incentivise quality and cost effectiveness rather than short-term cost reduction. [11]

Contacts

MTG lists its PR and lobbying company Weber Shandwick as the Group's secretariat and contact point.

Care of /Weber Shandwick
Fox Court
14 Gray’s Inn Road
London, WC1X 8WS

Use this mail, mail@mtg.org.uk, if you want to contact the MTG secretariat. [12]

References

  1. ↑ ABHI website Medical Technology Group, accessed Feb 2011
  2. ↑ MTG website Competitors, accessed Feb 2011
  3. ↑ AdvaMed website Associate Members, accessed Mars 2011
  4. ↑ Nursing Times website NHS 'must boost use of technology' or risk falling behind, accessed April 2011
  5. ↑ Scottish Healthcare website Medical Technology Group Warns Against ‘Slow-Tech’ NHS, accessed April 2011
  6. ↑ HM Government [http://www.bis.gov.uk/assets/biscore/business-sectors/docs/s/10-p90-strength-and-opportunity-bioscience-and-health-technology-sectors.pdf Strength and Opportunity], accessed Mars 2011
  7. ↑ MTG website MTG Policy Statements, accessed Feb 2011
  8. ↑ MTG website Members, accessed Feb 2011
  9. ↑ MTG website Members, accessed Nov 2010
  10. ↑ Achieving QIPP through improved use of technology in the NHS [1], accessed Feb 2011
  11. ↑ Achieving QIPP through improved use of technology in the NHS, accessed Feb 2011
  12. ↑ MTG website MEDICAL TECHNOLOGY AND INNOVATION, accessed Feb 2011
Retrieved from "https://powerbase.info/index.php?title=Medical_Technology_Group&oldid=154266"